Neurocenter - Saarland University Hospital, Homburg/Saar, Germany.
World J Biol Psychiatry. 2011 Sep;12 Suppl 1:89-94. doi: 10.3109/15622975.2011.603229.
It is now widely accepted that ADHD is a frequent chronic condition with a lifelong perspective. Adult ADHD is a reliable and valid diagnosis. The disorder and the co-morbid conditions can place a severe burden on the patients, their families and their partners, requiring adequate treatment.
A systematic literature search was conducted to review the available pharmacological treatment options for adults with ADHD in European countries.
Supported by meta-analyses, stimulant medication is the first-line pharmacological therapy for adult ADHD. However, from a European perspective the pharmacological treatment options are very limited and only a minority of adults with ADHD in European countries receives adequate treatment.
With reference to the epidemiological data, it seems very likely that the number of people with ADHD in Europe seeking multimodal treatment including pharmacotherapy, psychotherapy, coaching or other therapeutic services will increase profoundly during the coming years.
目前广泛认为，ADHD 是一种常见的慢性疾病，具有终身性。成人 ADHD 是一种可靠且有效的诊断。该疾病及其合并症会给患者、患者的家人和伴侣带来严重的负担，需要进行充分的治疗。
进行了系统的文献检索，以回顾欧洲国家成人 ADHD 患者可用的药物治疗选择。
基于荟萃分析，兴奋剂药物是成人 ADHD 的一线药物治疗选择。然而，从欧洲的角度来看，药物治疗选择非常有限，只有少数欧洲国家的 ADHD 患者接受了充分的治疗。
根据流行病学数据，在未来几年，欧洲寻求包括药物治疗、心理治疗、辅导或其他治疗服务在内的多模式治疗的 ADHD 患者数量很可能会大幅增加。
